NCT02924272 2025-03-12
Ixazomib Rollover Study
Takeda
Phase 2 Completed
Clinical Trials
4 trialsNCT03439293 2024-07-03
A Study of Ixazomib+Daratumumab+Dexamethasone (IDd) in Relapsed and/or Refractory Multiple Myeloma (RRMM)
Takeda
Phase 2 Completed
NCT03733691 2023-10-25
Ph 2 Maintenance Trial: Ixazomib vs Ixazomib-Lenalidomide for MM Patients
Oncotherapeutics
Phase 2 Terminated
NCT03608501 2020-01-14
IDEALL
Takeda
Phase 2 Withdrawn